Auto-Titrating Continuous Positive Airway Pressure for Patients With Acute Transient Ischemic Attack | Zendy

Dawn M. Bravata | Zendy; John Concato | Zendy; Terri R. Fried | Zendy; Noshene Ranjbar | Zendy; Tanesh Sadarangani | Zendy; Vincent McClain | Zendy; Frederick A. Struve | Zendy; Lawrence Zygmunt | Zendy; Herbert Knight | Zendy; Albert Lo | Zendy; George B. Richerson | Zendy; Mark Gorman | Zendy; Linda S. Williams | Zendy; Lawrence Brass | Zendy; Joseph V. Agostini | Zendy; Vahid Mohsenin | Zendy; Francoise Roux | Zendy; H. Klar Yaggi | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Auto-Titrating Continuous Positive Airway Pressure for Patients With Acute Transient Ischemic Attack

Author(s) -

Dawn M. Bravata,

John Concato,

Terri R. Fried,

Noshene Ranjbar,

Tanesh Sadarangani,

Vincent McClain,

Frederick A. Struve,

Lawrence Zygmunt,

Herbert Knight,

Albert Lo,

George B. Richerson,

Mark Gorman,

Linda S. Williams,

Lawrence Brass,

Joseph V. Agostini,

Vahid Mohsenin,

Francoise Roux,

H. Klar Yaggi

Publication year - 2010

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.109.566745

Subject(s) - medicine , continuous positive airway pressure , polysomnography , sleep apnea , apnea , obstructive sleep apnea , stroke (engine) , apnea–hypopnea index , anesthesia , heart failure , cardiology , mechanical engineering , engineering

Transient ischemic attack (TIA) patients are at risk of recurrent vascular events. The primary objectives were to evaluate among TIA patients the prevalence of sleep apnea and among patients with sleep apnea auto-titrating continuous positive airway pressure (auto-CPAP) adherence. The secondary objective was to describe among TIA patients with sleep apnea the recurrent vascular event rate by auto-CPAP use category.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research